Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

European Commission approves Cara’s Kapruvia®

Cara Therapeutics reports that the European Commission has granted marketing authorization to Kapruvia® (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in...

| By Kelley Gipson

Yale Blavatnik funding to develop new projects

Yale University has announced its largest ever round of Blavatnik awards: a total of 12 new projects have received over $3 million in accelerator funding. The...

| By Kelley Gipson

BioCT welcomes new member CYduct Diagnostics

CYduct Diagnostics is focused on transformative products that will enable physicians to intervene at the earliest stages of breast cancer. The company currently develops, produces, and...

| By Kelley Gipson

Weekly Roundup – May 5, 2022 

View this email in your browser Weekly Roundup – May 5, 2022                             ...

| By Kelley Gipson

NanoViricides may offer anti-COVID gummies

NanoViricides, a Shelton-based company, says its anti-COVID medication candidate would come in a variety of forms, from gummies to inhalants. The company says it is...

| By Kelley Gipson

BioCT welcomes new member Ciencia

Ciencia’s patented Centinela system aims to provide on-site laboratory-quality answers to key clinical questions, ultimately permitting clinical evaluation, laboratory diagnosis, and therapy initiation during the...

| By Kelley Gipson

AI Therapeutics acquires Spanish cancer drug

Guilford-based AI Therapeutics, a drug company founded by entrepreneur Jonathan Rothberg, has acquired a new cancer drug candidate from Spain’s EntreChem, S.L. The new candidate, EC-8042...

| By Kelley Gipson

HBJ/NHB ‘Best Places to Work in CT’

“This year’s honorees have gone above and beyond to find creative, strategic, and safe ways to make work fun, inclusive and forward-thinking places for employees...

| By Kelley Gipson

Weekly Roundup – April 28, 2022 

View this email in your browser Weekly Roundup – April 28, 2022                           ...